Akanda Corp Stock Today
| AKAN Stock | USD 1.37 0.03 2.14% |
Performance0 of 100
| Odds Of DistressOver 85
|
Akanda Corp is selling at 1.37 as of the 21st of November 2024; that is 2.14% down since the beginning of the trading day. The stock's open price was 1.4. Akanda Corp has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Akanda Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of May 2024 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 15th of March 2022 | Category Healthcare | Classification Health Care |
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom. The company has 1.43 M outstanding shares of which 104.18 K shares are presently shorted by private and institutional investors with about 0.06 trading days to cover. More on Akanda Corp
Moving together with Akanda Stock
| 0.61 | VRAX | Virax Biolabs Group | PairCorr |
| 0.78 | DYN | Dyne Therapeutics | PairCorr |
| 0.81 | XFOR | X4 Pharmaceuticals | PairCorr |
Moving against Akanda Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Akanda Stock Highlights
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Management, Drugs, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAkanda Corp can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Akanda Corp's financial leverage. It provides some insight into what part of Akanda Corp's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Akanda Corp (AKAN) is traded on NASDAQ Exchange in USA. It is located in 1a, 1b Learoyd Road, New Romney, United Kingdom, TN28 8XU and employs 6 people. Akanda Corp is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.95 M. Akanda Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 1.43 M outstanding shares of which 104.18 K shares are presently shorted by private and institutional investors with about 0.06 trading days to cover.
Akanda Corp generates negative cash flow from operations
Check Akanda Corp Probability Of Bankruptcy
Ownership AllocationAlmost 97.9 percent of Akanda Corp outstanding shares are held by general public with 1.65 (percent) owned by insiders and only 0.45 % by other corporate entities.
Check Akanda Ownership Details
Akanda Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Tower Research Capital Llc | 2024-06-30 | 4.1 K | |
| Virtu Financial Llc | 2024-06-30 | 0.0 | |
| Ubs Group Ag | 2024-06-30 | 0.0 | |
| Citadel Advisors Llc | 2024-06-30 | 0.0 | |
| Hrt Financial Llc | 2024-06-30 | 0.0 |
Akanda Corp Historical Income Statement
Akanda Stock Against Markets
Akanda Corp Corporate Management
| Thomas Flow | Chief Officer | Profile | |
| BComm BCom | Ex Chairman | Profile | |
| Tejinder Virk | CEO Director | Profile | |
| BA MA | Chief Officer | Profile | |
| BCom BAcc | CFO Sec | Profile |
Already Invested in Akanda Corp?
The danger of trading Akanda Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Akanda Corp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Akanda Corp. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Akanda Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Akanda Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akanda Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akanda Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akanda Corp Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akanda Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Akanda Stock, please use our How to Invest in Akanda Corp guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akanda Corp. If investors know Akanda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akanda Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (524.76) | Revenue Per Share 9.388 | Quarterly Revenue Growth 2.705 | Return On Assets (0.26) | Return On Equity (2.43) |
The market value of Akanda Corp is measured differently than its book value, which is the value of Akanda that is recorded on the company's balance sheet. Investors also form their own opinion of Akanda Corp's value that differs from its market value or its book value, called intrinsic value, which is Akanda Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akanda Corp's market value can be influenced by many factors that don't directly affect Akanda Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akanda Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akanda Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akanda Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.